ESSA Pharma Statistics
Share Statistics
ESSA Pharma has 44.39M
shares outstanding. The number of shares has increased by 0.06%
in one year.
| Shares Outstanding | 44.39M |
| Shares Change (YoY) | 0.06% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 74.21% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,909 |
| FTD / Avg. Volume | 2.41% |
Short Selling Information
The latest short interest is 695.08K, so 1.57% of the outstanding
shares have been sold short.
| Short Interest | 695.08K |
| Short % of Shares Out | 1.57% |
| Short % of Float | 2.01% |
| Short Ratio (days to cover) | 4.43 |
Valuation Ratios
The PE ratio is -9.4 and the forward
PE ratio is -3.49.
ESSA Pharma's PEG ratio is
-1.41.
| PE Ratio | -9.4 |
| Forward PE | -3.49 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 2.09 |
| P/FCF Ratio | -11.81 |
| PEG Ratio | -1.41 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for ESSA Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 38.64,
with a Debt / Equity ratio of 0.
| Current Ratio | 38.64 |
| Quick Ratio | 38.64 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-815,509.17 |
| Employee Count | 35 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -70.19% in the
last 52 weeks. The beta is 1.69, so ESSA Pharma's
price volatility has been higher than the market average.
| Beta | 1.69 |
| 52-Week Price Change | -70.19% |
| 50-Day Moving Average | 1.66 |
| 200-Day Moving Average | 2.85 |
| Relative Strength Index (RSI) | 53.22 |
| Average Volume (20 Days) | 161,917 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -34.42M |
| Net Income | -28.54M |
| EBITDA | -28.45M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.64 |
Full Income StatementBalance Sheet
The company has 103.71M in cash and 329.26K in
debt, giving a net cash position of 103.38M.
| Cash & Cash Equivalents | 103.71M |
| Total Debt | 329.26K |
| Net Cash | 103.38M |
| Retained Earnings | n/a |
| Total Assets | 115.42M |
| Working Capital | 86.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -22.72M
and capital expenditures 0, giving a free cash flow of -22.72M.
| Operating Cash Flow | -22.72M |
| Capital Expenditures | n/a |
| Free Cash Flow | -22.72M |
| FCF Per Share | -0.51 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
